Baxion
Screening
Tags
Alerts
Theme
Aquestive Therapeutics, Inc.
AQST
·
NASDAQ
·
$4.08
Share Price as of 11/2
·
$405M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/11/26
10-Q
Q1 ended 03/31/26
05/13/26
10-K
FY 2025
03/04/26
10-Q
Q3 ended 09/30/25
11/05/25
10-Q
Q2 ended 06/30/25
08/11/25
Disclosures
Filter
8-K
Current report
10/19/26
8-K
Current report
10/15/26
8-K
Current report
10/14/26
8-K
Current report
09/29/26
8-K
Current report
09/25/26
Prospectuses and Registrations
Filter
424B3
Prospectus
07/09/26
S-3
Shelf registration
06/26/26
S-8
Registration of securities for employees
03/04/26
S-8
Registration of securities for employees
01/21/26
424B5
Prospectus supplement
08/14/25
Proxies
Filter
DEF 14A
Definitive proxy
04/24/26
DEFA14A
Additional proxy materials
04/24/26
DEF 14A
Definitive proxy
04/25/25
DEFA14A
Additional proxy materials
04/25/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
Form 4
Insider transaction
10/23/26
Form 3
Initial insider ownership
10/16/26
Form 4
Insider transaction
10/16/26
SC 13G
Beneficial ownership
10/07/26
SC 13G/A
Beneficial ownership (amended)
10/07/26
Other
Filter
EFFECT
Request for effectiveness
07/08/26
ARS
Annual report to shareholders
04/24/26
ARS
Annual report to shareholders
04/25/25
ARS
Annual report to shareholders
04/26/24
EFFECT
Request for effectiveness
04/23/24
Latest Filings
Filter
8-K
Current report
10/19/26
8-K
Current report
10/15/26
8-K
Current report
10/14/26
8-K
Current report
09/29/26
8-K
Current report
09/25/26
Ownership
Filter
Form 4
Insider transaction
10/23/26
Form 3
Initial insider ownership
10/16/26
Form 4
Insider transaction
10/16/26
SC 13G
Beneficial ownership
10/07/26
SC 13G/A
Beneficial ownership (amended)
10/07/26